These results showed that the expression level of AURKA in each mouse in MLN8237-treated group was associated with the tumor size (Fig. 7b, d), indicating that MLN8237-induced AURKA upregulation may lead to a less than expected effect of MLN8237 on neuroblastoma. Here, AURKA is linked to neoplasm.